J Gynecol Oncol.  2011 Mar;22(1):57-60. 10.3802/jgo.2011.22.1.57.

Early port-site metastasis during neoadjuvant chemotherapy in advanced stage ovarian cancer: report of two cases

• Ozmen B
• Sukur YE
• Atabekoglu CS
• Heper AO
• Sonmezer M
• Gungor M

• KMID: 2173588
• DOI: http://doi.org/10.3802/jgo.2011.22.1.57

Abstract

Port-site metastases in gynecological malignancies subsequent to laparoscopy have been reported with an incidence of 1.1-16%. These metastases tend to be disappearing after primary debulking surgery and subsequent primary chemotherapy. Local resection, chemotherapy and/or radiotherapy have been defined in the management of these metastases with enhanced clinical success. However, in extremely rare cases these metastases were also defined very early during neoadjuvant chemotherapy. Herein, we present two ovarian cancer cases which are clinically diagnosed with port site metastasis during neoadjuvant chemotherapy following diagnostic laparoscopy. Although neoadjuvant chemotherapy is sometimes needed in cases of fully advanced ovarian cancers, port-site metastasis may be encountered during neoadjuvant chemotherapy. The possible poor prognosis of these patients, especially those who have ascites, should make us careful in performing diagnostic laparoscopy with preventive measures for port-site metastasis and to start the chemotherapy immediately.

Keyword

Early port-site metastasis; Laparoscopy; Neoadjuvant chemotherapy; Ovarian cancer

MeSH Terms

Ascites
Humans
Incidence
Laparoscopy
Neoplasm Metastasis
Ovarian Neoplasms
Prognosis

Figure

• 

  Fig. 1 Metastatic tumor nodule with evident papillary pattern in the subcutaneous adipose tissue (H&E, ×40).

Reference

1. Brun JL, Rouzier R, Uzan S, Darai E. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol. 2008. 110:354–359.

2. Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol. 1998. 71:431–436.

3. Angioli R, Palaia I, Zullo MA, Muzii L, Manci N, Calcagno M, et al. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol. 2006. 100:455–461.

4. Fagotti A, Fanfani F, Ludovisi M, Lo Voi R, Bifulco G, Testa AC, et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol. 2005. 96:729–735.

5. Carlson NL, Krivak TC, Winter WE 3rd, Macri CI. Port site metastasis of ovarian carcinoma remote from laparoscopic surgery for benign disease. Gynecol Oncol. 2002. 85:529–531.

6. Dobronte Z, Wittmann T, Karacsony G. Rapid development of malignant metastases in the abdominal wall after laparoscopy. Endoscopy. 1978. 10:127–130.

7. Childers JM, Aqua KA, Surwit EA, Hallum AV, Hatch KD. Abdominal-wall tumor implantation after laparoscopy for malignant conditions. Obstet Gynecol. 1994. 84:765–769.

8. van Dam PA, DeCloedt J, Tjalma WA, Buytaert P, Becquart D, Vergote IB. Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: can the risk be reduced? Am J Obstet Gynecol. 1999. 181:536–541.

9. Nagarsheth NP, Rahaman J, Cohen CJ, Gretz H, Nezhat F. The incidence of port-site metastases in gynecologic cancers. JSLS. 2004. 8:133–139.

10. Kruitwagen RF, Swinkels BM, Keyser KG, Doesburg WH, Schijf CP. Incidence and effect on survival of abdominal wall metastases at trocar or puncture sites following laparoscopy or paracentesis in women with ovarian cancer. Gynecol Oncol. 1996. 60:233–237.

11. Vergote I, Marquette S, Amant F, Berteloot P, Neven P. Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer. 2005. 15:776–779.

12. Ramirez PT, Wolf JK, Levenback C. Laparoscopic port-site metastases: etiology and prevention. Gynecol Oncol. 2003. 91:179–189.

13. Huang KG, Wang CJ, Chang TC, Liou JD, Hsueh S, Lai CH, et al. Management of port-site metastasis after laparoscopic surgery for ovarian cancer. Am J Obstet Gynecol. 2003. 189:16–21.

14. Wang PH, Yuan CC, Lin G, Ng HT, Chao HT. Risk factors contributing to early occurrence of port site metastases of laparoscopic surgery for malignancy. Gynecol Oncol. 1999. 72:38–44.